What's Happening?
EVERSANA has appointed Jen Norton as the president of its Market Access & Value division. Norton will lead the development of a technology-first, fully integrated market access business unit. Her role involves helping life sciences companies secure optimal
pricing and ensure broad payer coverage for therapies. Norton brings over two decades of experience, having previously held leadership roles at Takeda Pharmaceuticals, Amgen, Biogen, and Vertex Pharma. Her appointment is part of EVERSANA's strategy to address the complexities of the global pricing and access landscape, including Medicare price negotiations and international trade tariffs.
Why It's Important?
Jen Norton's appointment is significant as it highlights EVERSANA's commitment to addressing the challenges of market access in the pharmaceutical industry. With increasing complexities in pricing and access, her leadership is expected to help clients navigate these challenges effectively. This move is crucial for pharmaceutical companies aiming to optimize their market strategies and ensure patient access to therapies. Norton's extensive experience in market access roles positions her to lead EVERSANA's efforts in providing comprehensive solutions to the evolving needs of the healthcare market.
